Agreement Covers Enzo Clinical Labs’ Service Area NEW YORK–Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has entered into an agreement with GeneNews (TSX: GEN), of Toronto, Canada, for exclusive rights to market GeneNews’ ColonSentry™, a proprietary blood test for colorectal cancer, in the states of New York and New Jersey. Enzo will undertake to […]

Dortmund, Germany and New Jersey, USA — The 1st user meeting on protein arrays in clinical applications was organized by Protagen, Germany, and focused on the increasing relevance of new markers and marker panels for drug development and therapy. Especially the potential of Protagen’s UNIarray® platform technology for identification and validation of reliable biomarkers for […]

Tecan announces global OEM agreement to supply fully automated solution for Hologic Cervista® molecular diagnostics HPV tests – Prototypes have already been successfully tested – The U.S. market launch of automated Cervista systems is expected in 2010 Männedorf, Switzerland — The Tecan Group (SIX Swiss Exchange: TECN) today announced a global OEM agreement with Hologic, […]

PENZBERG, Germany–Roche`s (SWX:RO) (SWX:ROG) (Pink Sheets: RHHBY) RealTime ready Influenza A/H1N1 Detection Set for the 2009 H1N1 influenza virus has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA). The Roche kit detects RNA from the 2009 H1N1 influenza A virus and allows rapid and accurate identification of patients infected with […]

Edinburgh — Lab901 (Edinburgh, UK) and Biofortuna (Liverpool, UK) today announced that they will collaborate on the launch of an automated PCR Dx system for the rapid detection of certain HLA-related diseases such as coeliac disease. Lab901 will be optimising its automated ScreenTape® PCR diagnostics platform for use with Biofortuna’s range of multiplex PCR diagnostics […]

Early Detection Will Save Lives and Reduce the Cost of Health Care SUNNYVALE, CA– Arrayit Corporation (OTC.BB:ARYC – News) announced today that the company’s majority owned subsidiary, Arrayit Diagnostics, Inc., will launch the most intensive marketing campaign in the company’s thirteen-year history. The company is currently developing several diagnostic tests that will provide early detection […]

BUFFALO, N.Y. — Rand Capital Corporation (Nasdaq:RAND) (“Rand”), a business development company (BDC) that provides capital and managerial expertise for small to medium-sized private companies, announced that it has invested $250,000 in Rheonix, Inc. (www.rheonix.com), based in Ithaca, New York. Rheonix began operations and was later spun out of the microfluidic division of Kionix, Inc. […]

Collaborative Efforts Leading to Advances That Will Contribute to Health Care Reform SUNNYVALE, CA — Arrayit Corporation (OTC.BB:ARYC – News) is pleased to join the federal government in their efforts to help control health care costs through early diagnosis of diseases. For more than 150 years, traditional medicine has relied on a ‘standards of care’ […]

New Agreement Covers Widespread Bacterial Infections in Horses VENLO, Netherlands–QIAGEN (NASDAQ:QGEN) (FWB:QIA) today announced an expansion of its strategic partnership with the United Kingdom’s Veterinary Laboratories Agency (VLA), one of the world’s leading research institutions in veterinary science. Under the terms of the agreement, QIAGEN has received the exclusive rights to commercialize three new PCR-based […]

Speaking at Bio-Europe 2009 Conference in Austria, Research and Clinical Studies for Treatment of Crohn’s Disease and Uveitis Cited VIENNA — Enzo Biochem, Inc. (NYSE:ENZ) today reported on the Company’s therapeutic platforms utilizing oral immune regulation for immune mediated diseases at the Bio-Europe 2009 15th Annual International Conference here calling it a “bright area of […]